These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 15096402)
1. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
2. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693 [TBL] [Abstract][Full Text] [Related]
4. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
5. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression. Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324 [TBL] [Abstract][Full Text] [Related]
7. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients]. Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019 [TBL] [Abstract][Full Text] [Related]
8. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
10. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis. Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142 [TBL] [Abstract][Full Text] [Related]
11. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [TBL] [Abstract][Full Text] [Related]
15. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H; J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633 [TBL] [Abstract][Full Text] [Related]
16. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879 [TBL] [Abstract][Full Text] [Related]
17. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Taylor WD; Macfall JR; Payne ME; McQuoid DR; Steffens DC; Provenzale JM; Krishnan KR Psychol Med; 2007 Dec; 37(12):1763-73. PubMed ID: 17335636 [TBL] [Abstract][Full Text] [Related]
18. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Diaz-Arrastia R; Gong Y; Fair S; Scott KD; Garcia MC; Carlile MC; Agostini MA; Van Ness PC Arch Neurol; 2003 Jun; 60(6):818-22. PubMed ID: 12810485 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment. Thomann PA; Roth AS; Dos Santos V; Toro P; Essig M; Schröder J Dement Geriatr Cogn Disord; 2008; 26(4):300-5. PubMed ID: 18843182 [TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]